ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 423,67
0,20%
Dow Jones
42 518,28
0,52%
DAX
20 271,33
0,67%
Brent Oil
79,465
-0,29%
Bitcoin
97 255,78
0,78%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Intercept Pharmaceuticals Inc (ICPT) Cours

Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals Inc (ICPT)

NASDAQ
19,00
0,00
(0,00%)
Fermé 15 Janvier 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
19,00
Prix Achat
18,66
Prix Vente
19,02
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
794,693M
Clôture Veille
19,00
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
41 825 966
Rendement du Dividende
-
Ratio Cours sur Bénéfices
3,58
Bénéfice par action (BPA)
5,3
Chiffre d'affairess
285,71M
Bénéfice net
221,82M

À propos de Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.interceptpharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-

ICPT Dernières nouvelles

Plus de nouvelles

Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference

MORRISTOWN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and...

09 Mai 2024
GlobeNewswire Inc.

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401...

29 Février 2024
GlobeNewswire Inc.

Form 15-12G - Securities registration termination [Section 12(g)]

20 Novembre 2023
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

15 Novembre 2023
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

15 Novembre 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Novembre 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Novembre 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Novembre 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Novembre 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Novembre 2023
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ICPT - Frequently Asked Questions (FAQ)

What is the current Intercept Pharmaceuticals share price?
The current share price of Intercept Pharmaceuticals is US$ 19,00
How many Intercept Pharmaceuticals shares are in issue?
Intercept Pharmaceuticals has 41 825 966 shares in issue
What is the market cap of Intercept Pharmaceuticals?
The market capitalisation of Intercept Pharmaceuticals is USD 794,69M
What is the 1 year trading range for Intercept Pharmaceuticals share price?
Intercept Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Intercept Pharmaceuticals?
The price to earnings ratio of Intercept Pharmaceuticals is 3,58
What is the cash to sales ratio of Intercept Pharmaceuticals?
The cash to sales ratio of Intercept Pharmaceuticals is 2,78
What is the reporting currency for Intercept Pharmaceuticals?
Intercept Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Intercept Pharmaceuticals?
The latest annual turnover of Intercept Pharmaceuticals is USD 285,71M
What is the latest annual profit for Intercept Pharmaceuticals?
The latest annual profit of Intercept Pharmaceuticals is USD 221,82M
What is the registered address of Intercept Pharmaceuticals?
The registered address for Intercept Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Intercept Pharmaceuticals website address?
The website address for Intercept Pharmaceuticals is www.interceptpharma.com
Which industry sector does Intercept Pharmaceuticals operate in?
Intercept Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
HEESH and E Equipment Services Inc
US$ 90,29
(105,48%)
13,29M
AIFFFirefly Neuroscience Inc
US$ 3,11
(63,68%)
131,28M
RGTIRigetti Computing Inc
US$ 8,94
(47,77%)
354,95M
ERNAEterna Therapeutics Inc
US$ 0,452561
(46,46%)
575,5M
TDUPThredUp Inc
US$ 1,88
(44,62%)
13,53M
WNWMeiwu Technology Company Ltd
US$ 1,00
(-66,67%)
12,78M
PHIOPhio Pharmaceuticals Corporation
US$ 3,5707
(-45,90%)
11,23M
MBIOMustang Bio Inc
US$ 0,1434
(-35,95%)
15,3M
BDMDBaird Medical Investment Holdings Ltd
US$ 7,695
(-30,74%)
493,77k
ATPCAgape ATP Corporation
US$ 1,3904
(-29,42%)
1,26M
ERNAEterna Therapeutics Inc
US$ 0,452561
(46,46%)
575,5M
RGTIRigetti Computing Inc
US$ 8,94
(47,77%)
354,95M
NVDANVIDIA Corporation
US$ 131,76
(-1,10%)
195,58M
GCTKGlucoTrack Inc
US$ 0,1216
(-18,77%)
172,89M
NMHINatures Miracle Holding Inc
US$ 1,5106
(33,68%)
167,17M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ICPT
Intercept Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés